Welcome to the website of the UK Chemotherapy Partnership – aiming to improve the quality and safety of chemotherapy delivery by sharing information, expertise and opinion. We open the door on the latest developments in chemotherapy service provision and give you access to NHS experts and their documentation to help you develop and improve your own service.

Chemotherapy service

Chemotherapy delivery can be complex and challenging. These are some of the practice innovations and developments within the UK aiming to improve the patient experience.

March 2016
Events & meetings

UKCP Systemic-Anti Cancer Therapy Masterclass
Programme to follow.  


Coming soon. We are very excited to announce this new online educational resource. It will initially include 6 modules on cancer and chemotherapy.

Our videos

Healthcare professionals sharing experiences of service developments, including patient information videos for patients embarking on the treatment pathway.

What's new

Achieving World-Class Outcomes-A Strategy for England 2015-2020

Five year plan to radically improve cancer outcomes.

2015 ASCO Annual Meeting-Highlights

Highlights from the 2015 ASCO Annual Meeting-Illumination & Innovation; Transforming Data into Learning

Recovery Package-Cancer Nursing Partnership

The CNP is working to roll out the Recovery Package

Understanding Cancer E-Learning

Understanding Cancer was launched in April 2012.


Latest news

Effect of exercise on breast cancer survivors

A researcher at Syracuse University has simple advice for breast cancer survivors struggling with the side effects of aromatase inhibitors (AIs): exercise. Gwendolyn Thomas, assistant professor of exercise science, is the co-author of an article in the...

Misperceptions of metastatic breast cancer (mBC) create added obstacles for treatment and care

A first-of-its-kind global report by Pfizer Oncology and the European School of Oncology (ESO) analyses the metastatic breast cancer landscape A diagnosis of mBC can be the beginning of a challenging journey for patients. MBC is often shroud-ed by...

Confirmed benefit for treating advanced NSCLC, though fifth of patients abstain

Non-small cell lung cancer (NSCLC) patients with advanced disease receiving standard of care treatment have a higher overall survival (OS) than similar patients not receiving treatment. Lung cancer is the leading cause of cancer deaths worldwide, causing...

Mayo researchers identify mechanism of oncogene action in lung cancer

In a new paper published this week in Cancer Cell, Mayo Clinic researchers provide genetic evidence that Ect2 drives lung adenocarcinoma tumour formation. "This paper demonstrates, for the first time, that Ect2 is required for tumour formation in vivo...

Digital assay of circulating tumour cells may improve diagnosis, monitoring of liver cancer

Use of an advanced form of the commonly used polymerase chain reaction (PCR) method to analyse circulating tumour cells (CTCs) may greatly increase the ability to diagnose early-stage cancer, increasing the likelihood of successful treatment. In their...